Sub-Investigator — Internal Medicine
Danay Suarez Falcon, MD
Board-certified internist and hospitalist committed to patient care and clinical research, with hospital and outpatient experience across multiple specialties and a focus on real-world needs of diverse patient populations.
Profile
Dr. Suarez Falcon joined Salud Clinical Services in January 2025. She completed internal medicine residency at University Hospital Ramon Ruiz Arnau in Bayamón, Puerto Rico, following general surgery training in Havana and several years of physician assistant practice in Florida.
Detail-oriented and collaborative, she supports protocol conduct, safety assessments, and participant follow-up across respiratory, infectious disease, and cardiometabolic studies.
- Profile
- Internal Medicine
- At Salud since
- 2025
- Languages
- English and Spanish (fluent, written and verbal)
Education and training
- Internal Medicine Residency — University Hospital Ramon Ruiz Arnau, Bayamón, PR, 2019–2022
- Hospitalist Internship — Hospitals HIMA, Cupey, PR, 2017–2019
- Physician Assistant — Miami, FL, 2013–2017
- General Surgery Residency — Hospital Carlos J. Finlay, Havana, Cuba, 2007–2009
- Doctor of Medicine — University of Medical Sciences of Havana, Cuba, 2001–2007
Licenses and certifications
- Florida State Medical License
- Federal Narcotics Medical License (DEA)
- Internal Medicine Board Certified (2022)
- ACLS and BLS Certified
- ECFMG certified (2016)
- Hospitalist Internship Certification
Professional experience
- Salud Clinical Services — 2025–Present
- Lee Physician Group, Cape Coral Hospital, Nocturnist/Hospitalist — 2022–Present
- Vitas Healthcare, Internal Medicine Physician, Naples, FL — 2024–Present
- Doctors Center Hospital, Carolina, PR, Moonlighting Nocturnist — 2021–2022
- Kendall Regional Medical Center, Physician Assistant, Endocrinology/Nuclear Medicine — 2013–2017
Professional organizations
- American College of Physicians
- American Medical Association
- Florida Medical Association
Clinical research experience
| Study focus | Phase | Sponsor | Years |
|---|---|---|---|
| Severe asthma in adults and adolescents | Phase 3 | GSK | 2022–2023 |
| COPD and chronic bronchitis, add-on to maintenance triple therapy | Phase 3 | Chiesi | 2022–2024 |
| Early COVID-19 treatment | Phase 2 | SyneuRx International | 2022 |
| Tiotropium bromide inhalation powder 18 µg bioequivalence | Phase 3 | Xiromed | 2022–2023 |
| Safety and immunogenicity of a COVID-19 vaccine booster dose | Phase 2/3 | Novavax | 2023 |
Frequently asked questions
Answers to questions we hear most often.
What is a Principal Investigator?
The Principal Investigator is the qualified clinician responsible for conducting the study at the site, protecting participant safety, and ensuring the protocol is followed.
Who will I see at my study visits?
Most visits are conducted by a clinical research coordinator, with the Principal Investigator or a sub-investigator involved in medical assessments and safety review.
Is the research staff trained in Good Clinical Practice?
Yes. GCP and protocol-specific training is completed and documented before staff are delegated study responsibilities.
Can I request a Spanish-speaking coordinator?
Yes. Our team is bilingual and visits can be conducted in English or Spanish.
Information on this website is provided for general educational purposes about clinical research and is not medical advice. Participation in any study is voluntary.